Clinical Trial Update: Ranibizumab Versus Aflibercept for CRVO in Young Patients. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ranibizumab and aflibercept for non-ischemic central retinal vein occlusion with macular edema in young patients; current status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-ischemic Central Retinal Vein Occlusion with Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: South Valley University | Conditions: Non-Ischemic Central Retinal Vein Occlusion With Macular Edema | Phase 4 | Status: UNKNOWN